Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
Volatile day for CAR-T biotechs after FDA reveals safety review
CAR-T therapy biotechs had a tough day at the market after the FDA announced a probe into secondary cancers that can occur after the treatments.
Annalee Armstrong
Nov 28, 2023 4:35pm
BMS, Avidity add another $100M to cardiovascular partnership
Nov 28, 2023 6:30am
Bayer's blood thinner fails phase 3, denting $5B sales forecast
Nov 20, 2023 5:00am
BMS snags another ADC with modest $100M Orum deal
Nov 6, 2023 7:00am
BMS taps Arch-backed startup to change cancer trial Paradigm
Oct 6, 2023 10:05am
BMS trims anti-TIGIT and a handful of other meds
Sep 14, 2023 1:57pm
